Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

No longer available × Neuroendocrine Tumors × Endocrine × Clear all

Status

Completed 171 Recruiting 102 Unknown 62 Active not recruiting 41 Terminated 38 Withdrawn 17 Not yet recruiting 12 Enrolling by invitation 5 No longer available 2 Approved for marketing 2 Suspended 1 Available 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

NET 2 Endocrine 2

Conditions

Pheochromocytoma 2 Neuroendocrine Tumors 2 Neuroblastoma 2 Paraganglioma 1 Carcinoid Tumor 1 Adenoma, Islet Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04814732 2024-04-12

Expanded Access Program of Surufatinib

Hutchmed

No longer available

Neuroendocrine Tumors

NCT02358018 2016-11-02

68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Memorial Sloan Kettering Cancer Center

No longer available

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡